← back to search

Feng Miao

Fudan University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, MicroRNA in disease regulation, and Hippo pathway signaling and YAP/TAZ.
h-index
15
citations
823
works
39
NIH funding
primary concept
email

Recent publications

Identifying disparities in germline and somatic testing for ovarian cancer
Gynecologic Oncology 2019cited by 39position: middledoi
<p>LINC00958-MYC positive feedback loop modulates resistance of head and neck squamous cell carcinoma cells to chemo- and radiotherapy in vitro</p>
OncoTargets and Therapy 2019cited by 39position: middledoi
LncRNA HAND2-AS1 inhibits non-small cell lung cancer migration, invasion and maintains cell stemness through the interactions with TGF-β1
Bioscience Reports 2018cited by 54position: firstdoi
miR‑381 and miR‑489 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/β‑catenin pathway in gastric cancer
International Journal of Oncology 2018cited by 29position: middledoi
Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer
Journal of Experimental & Clinical Cancer Research 2017cited by 71position: middledoi
Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway
Oncotarget 2016cited by 76position: middledoi
MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1
Cellular Physiology and Biochemistry 2015cited by 77position: middledoi
MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1
Tumor Biology 2015cited by 57position: middledoi
Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile
Tumor Biology 2015cited by 49position: middledoi
Factors associated with contralateral preventive mastectomy
Breast Cancer Targets and Therapy 2015cited by 18position: middledoi
miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1
Biochemical and Biophysical Research Communications 2014cited by 96position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jianping Xiong · Jiangxi Normal University8 papers (2014–2019)Jun Deng · Sun Yat-sen University6 papers (2014–2019)Feng Yu · Nanchang University5 papers (2014–2017)Jun Chen · Vanderbilt University Medical Center5 papers (2015–2018)Ziling Fang · Tulane University3 papers (2016–2018)Zhengyu Zhan · Nanchang University2 papers (2016–2019)Ling Zhang · Fujian Medical University2 papers (2015–2016)Hui Guo · Nanchang University2 papers (2018–2019)Yangyang Yao · Nanchang University2 papers (2018–2019)Tulay Koru‐Sengul · University of Miami2 papers (2015–2019)Luying Wan · Nanchang University2 papers (2014–2015)Yi Wang · North Sichuan Medical University2 papers (2017–2018)Lei Wan · Nanchang University2 papers (2015–2016)Zhe Sun · Guangzhou University of Chinese Medicine2 papers (2014–2015)Yang Song · Fudan University1 papers (2018–2018)Xiang Yuan · Heilongjiang University of Chinese Medicine1 papers (2018–2018)Quan Liao · Xiamen University1 papers (2017–2017)Ji Chen · Fudan University1 papers (2018–2018)Min Zhong · Nanchang University1 papers (2018–2018)Ling Zhang · Guangzhou University of Chinese Medicine1 papers (2017–2017)